LINC00363: A Protein with Potential as a Drug Target or Biomarker

Target Name: LINC00363

NCBI ID: G104326053

LINC00363

Other Name(s): TCONS_00021586 | Long intergenic non-protein coding RNA 363 | long intergenic non-protein coding RNA 363

LINC00363: A Protein with Potential as a Drug Target or Biomarker

LINC00363 (TCONS-00021586) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the TCON family, which includes several similar proteins that play a critical role in the regulation of cellular processes, including cell adhesion, migration, and survival.

One of the most promising aspects of LINC00363 is its potential as a drug target. Its unique structure and subcellular localization have led to the hypothesis that it may serve as a useful target for the treatment of various diseases, including cancer, neurodegenerative disorders, and chronic kidney disease.

In addition to its potential therapeutic applications, LINC00363 has also been the subject of intense research in the field of neuroscience. Its expression has been observed in a wide range of neural tissues, including neurons, glial cells, and microglia, and its localization to the cell surface has led to the hypothesis that it may play a critical role in the regulation of neural circuitry.

One of the key challenges in studying LINC00363 is its subcellular localization. While it is known to be expressed in the brain and other tissues, its exact location and mechanisms of transport are not well understood. However, recent studies have suggested that LINC00363 may be transported by a process similar to the transport of other proteins, such as the endoplasmic reticulum-to-cytoplasmic transport (ER-CPT) system.

Another promising aspect of LINC00363 is its potential to serve as a biomarker for various diseases. Its expression has been observed in a wide range of tissues and conditions, including cancer, neurodegenerative disorders, and chronic kidney disease. Additionally, its unique structure and subcellular localization have led to the hypothesis that it may be a useful target for diagnostic tests, such as imaging agents or therapeutic antibodies.

In conclusion, LINC00363 is a protein that has the potential to serve as a drug target or biomarker for a wide range of diseases. Its unique structure and subcellular localization, as well as its expression in a wide range of tissues and conditions, make it an attractive target for further study. Further research is needed to fully understand its mechanisms of transport and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 363

The "LINC00363 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00363 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets